The category of Type II 4-phosphatase β Inhibitors would encompass a diverse array of compounds with the capability to modulate the activity of type II phosphatases or affect related cellular signaling cascades. These inhibitors operate through a variety of mechanisms, underscoring the complexity and critical nature of phosphatase functions in cellular processes. Direct inhibitors such as Sodium orthovanadate and Calyculin A demonstrate the capacity to alter signaling pathways by affecting the phosphorylation state of proteins. This modulation is essential for the regulation of numerous cellular functions, including growth, differentiation, and apoptosis, highlighting the significance of phosphatases in maintaining cellular homeostasis.
Moreover, the inclusion of compounds like Okadaic acid and Cantharidin offers insights into the regulatory mechanisms that govern cell cycle progression and signal transduction. Their specific inhibition of protein phosphatases like PP1 and PP2A points to the potential for targeted modulation of phosphatase activity as a means to study and influence the complex networks of cellular signaling. Additionally, natural toxins such as Microcystin-LR emphasize the potent effects that phosphatase inhibition can exert on cellular physiology, affecting a broad range of biological processes from cytoskeletal organization to gene expression.
In sum, this theoretical class of Type II 4-phosphatase β Inhibitors illustrates the critical roles that phosphatases play in regulating cellular functions and the potential for chemical compounds to influence these processes through direct or indirect interactions. By targeting the activity of these enzymes, it is possible to affect a wide array of biological pathways, offering a window into the sophisticated signaling networks that underpin cellular behavior. This approach not only provides a foundation for understanding the impact of phosphatase modulation on cell physiology but also underscores the intricate balance of phosphorylation and dephosphorylation events essential for proper cellular function.
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | ¥508.00 ¥632.00 ¥2065.00 | 142 | |
Actúa como inhibidor competitivo de las proteínas tirosina fosfatasas, alterando los estados de fosforilación. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | ¥1805.00 ¥8462.00 ¥15795.00 ¥33846.00 | 59 | |
Inhibe fuertemente las proteínas fosfatasas 1 y 2A, lo que podría afectar a las actividades de las fosfatasas relacionadas. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | ¥3215.00 ¥5867.00 ¥14667.00 | 78 | |
Se dirige a las proteínas fosfatasas PP1 y PP2A, alterando potencialmente las vías de señalización en las que intervienen fosfatasas similares. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | ¥914.00 ¥2933.00 | 6 | |
Inhibe les phosphatases à sérine/thréonine, y compris PP2A, ce qui peut influencer la signalisation de la phosphatase correspondante. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | ¥2933.00 | 9 | |
Inhibidor selectivo de PP2A y PP4, podría afectar a vías de señalización mediadas por fosfatasas similares. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | ¥1907.00 ¥3373.00 | 66 | |
Inhibe la PP1 y la PP2A, afectando a la dinámica de fosforilación y a las vías de señalización de las enzimas relacionadas. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | ¥542.00 ¥2245.00 | 1 | |
Actúa contra PP2A, influyendo potencialmente en las vías que implican fosfatasas de tipo II similares. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | ¥451.00 | 4 | |
Se une e inhibe las tirosina fosfatasas, afectando potencialmente a las vías de señalización de las enzimas relacionadas. | ||||||
Bialaphos Sodium Salt | 71048-99-2 | sc-280620 sc-280620A | 100 mg 500 mg | ¥5077.00 ¥11192.00 | 1 | |
Aunque su acción principal es sobre la síntesis de proteínas, podría influir indirectamente en la actividad de las fosfatasas. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | ¥372.00 ¥1151.00 | 87 | |
Se dirige indirectamente a las fosfatasas implicadas en el estrés del RE, afectando potencialmente a enzimas relacionadas. | ||||||